Leaflet PARECOXIB NORIDEM 40mg powder for solution for injection

Indicated for: pain and inflammation

Route of administration: injectable

Substance: parecoxib (nonsteroidal anti-inflammatory drug)

ATC: M01AH04 (Musculo-skeletal system | Antiinflammatory and antirheumatic products, non-steroids | Coxibs)

Precautions:
Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Nephrotoxicity
Nephrotoxicity

This medicine may affect the kidneys.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Bleeding risk
Bleeding risk

This medicine may increase the risk of bleeding.

Ulcer / gastrointestinal bleeding
Ulcer / gastrointestinal bleeding

This medicine may increase the risk of ulcer or gastrointestinal bleeding.

Parecoxib is a nonsteroidal anti-inflammatory drug (NSAID) used for the treatment of acute postoperative pain. It is a selective cyclooxygenase-2 (COX-2) inhibitor that reduces inflammation and pain without significantly affecting the gastric mucosa.

The medication is administered intravenously or intramuscularly, as directed by your doctor. It is important to follow the prescribed dosage and not to use the medication long-term without medical supervision.

Side effects may include nausea, dizziness, injection site reactions, or, in rare cases, severe allergic reactions or kidney function impairment.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as cardiovascular or kidney diseases, to ensure the safe use of parecoxib.

General data about PARECOXIB NORIDEM 40mg

  • Substance: parecoxib
  • Date of latest medicines list: 01-05-2026
  • Product code: W71814001
  • Concentration: 40mg
  • Pharmaceutical form: powder for solution for injection
  • Quantity: 10
  • Product type: Generic medicine
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA
  • Holder: NORIDEM ENTERPRISES LIMITED - CIPRU
  • Number: 16515/2026/01
  • Shelf life: 3 years-after packing for marketing;after reconstituting the solution-it is used immediately

Concentrations available for parecoxib

  • 20mg
  • 40mg